Or. Admin. R. 855-115-0350 – Services: Prescribing Practices - Short-acting Opioid Antagonists

(1) A Pharmacist may prescribe any FDA approved short-acting opioid antagonist (e.g., naloxone, nalmefene) and the necessary medical supplies to administer a short-acting opioid antagonist for opiate overdose:
1. (a) When dispensing any opiate or opioid prescription in excess of 50 morphine milligram equivalents (MME);
2. (b) To an individual seeking a short-acting opioid antagonist;
3. (c) To an entity seeking a short-acting opioid antagonist.
(2) A Pharmacist is not required to label the prescription according to OAR 855-041-1130 if dispensing a FDA approved short-acting opioid antagonist in the form of a nasal spray.
(3) The Pharmacist must document the encounter, the prescription and maintain records according to OAR 855-104-0055.

ORS 689.205

ORS 689.305, ORS 689.681, ORS 689.682 & ORS 689.684